NCT01780766Unknown不适用
Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI: What is the Added Value of Diffusion Weighted Imaging in Diagnosis and Follow-up
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Validation
研究概览
简要总结
Whole body MRI with diffusion weighted imaging is a useful imaging tool
- staging and diagnosis
- therapy monitoring All patients will be scanned before and during treatment. The findings on diffusion weighted imaging will be correlated to the golden standard (computer tomography and MRI (T1 and STIR)).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 25 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with clinical and laboratory findings, highly suggestive for multiple myeloma.
排除标准
- •All patients who are not allowed to be scanned on MRI (Pacemaker, implants ed.)
结局指标
主要结局
Validation
时间窗: 2 years
Validation of whole body MRI diffusion-weighted imaging in multiple myeloma at 3 Tesla MRI: correlation of the new MRI imaging technique (diffusion weighted imaging)to standard validated imaging technique (Computer Tomography and Magnetic Resonance Imaging)
次要结局
- Therapy assessment(4 years)
研究者
Steven Pans
Medical Doctor Radiologist
Universitaire Ziekenhuizen KU Leuven
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate CancerProstate CarcinomaNCT03085043M.D. Anderson Cancer Center98
已完成
不适用
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate CancersHead and Neck CancerProstate CancerNCT01535898Memorial Sloan Kettering Cancer Center10
进行中（未招募）
不适用
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of LymphomaNon-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma)Hodgkin LymphomaLymphomaNCT01231269Universitaire Ziekenhuizen KU Leuven100
Unknown
不适用
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic CancersMetastatic BreastcancerNCT02966574Brugmann University Hospital50
已完成
不适用
Imageguided Theranostics in Multiple MyelomaMyelomaCancerNCT02403102Institute of Cancer Research, United Kingdom61